LENZ Therapeutics, Inc. (LENZ) Ownership

$20.26

north_east
$1.72 (9.28%)
Day's range
$18.13
Day's range
$20.39

LENZ Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 4.18 M $120.64 M   0.00% 15.38%
ALPHA WAVE GLOBAL, LP 02/13/2025 3.61 M $104.28 M   0.00% 13.29%
BLACKROCK, INC. 02/07/2025 1.16 M $33.36 M   24.26% 4.25%
72 INVESTMENT HOLDINGS, LLC 02/14/2025 1.02 M $29.38 M   0.00% 3.75%
SAMSARA BIOCAPITAL, LLC 02/14/2025 986,981 $28.49 M   -18.33% 3.63%
SECTORAL ASSET MANAGEMENT INC 02/14/2025 977,245 $28.21 M   0.00% 3.60%
RTW INVESTMENTS, LP 02/14/2025 863,389 $24.93 M   0.00% 3.18%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 783,921 $22.63 M   -9.37% 2.89%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 770,455 $22.24 M   100.00% 2.84%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 766,940 $22.14 M   0.00% 2.82%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 334,026 $9.65 M   -1.18% 1.23%
IKARIAN CAPITAL, LLC 02/14/2025 149,502 $4.32 M   -26.90% 0.55%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 142,113 $4.10 M   16.38% 0.52%
NORTHERN TRUST CORP 02/14/2025 139,288 $4.02 M   7.44% 0.51%
TD ASSET MANAGEMENT INC 02/11/2025 103,000 $2.97 M   263.83% 0.38%
MORGAN STANLEY 02/14/2025 92,284 $2.66 M   82.82% 0.34%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 67,891 $1.96 M   116.84% 0.25%
VIVALDI CAPITAL MANAGEMENT LP 02/14/2025 56,252 $1.39 M   -4.26% 0.21%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 51,842 $1.50 M   100.00% 0.19%
HARBOR CAPITAL ADVISORS, INC. 01/10/2025 43,989 $1.27 M   100.00% 0.16%
BBR PARTNERS, LLC 02/07/2025 40,000 $1.15 M   0.00% 0.15%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 39,746 $1.15 M   -26.91% 0.15%
BANK OF AMERICA CORP /DE/ 02/14/2025 38,246 $1.10 M   92.67% 0.14%
AMERICAN CENTURY COMPANIES INC 02/11/2025 32,506 $938,448   36.15% 0.12%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 29,305 $846,035   100.00% 0.11%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 28,216 $814,596   14.60% 0.10%
KESTRA PRIVATE WEALTH SERVICES, LLC 01/28/2025 27,304 $788,266   -0.73% 0.10%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 25,366 $732,316   -48.51% 0.09%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 23,130 $667,763   0.00% 0.09%
DELTA INVESTMENT MANAGEMENT, LLC 02/18/2025 19,241 $555,488   100.00% 0.07%
RHUMBLINE ADVISERS 01/30/2025 18,754 $541,418   6.23% 0.07%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 17,716 $511,461   100.00% 0.07%
CITIGROUP INC 02/12/2025 17,453 $503,868   90.81% 0.06%
TWO SIGMA INVESTMENTS, LP 02/14/2025 17,079 $493,071   -33.04% 0.06%
KELLEHER FINANCIAL ADVISORS 01/17/2025 17,023 $491,454   -18.05% 0.06%
RINKEY INVESTMENTS 02/14/2025 15,186 $438,420   0.00% 0.06%
BML CAPITAL MANAGEMENT, LLC 02/07/2025 9,271 $267,654   -84.55% 0.03%
LEGAL & GENERAL GROUP PLC 02/13/2025 8,742 $252,382   703.49% 0.03%
RAYMOND JAMES FINANCIAL INC 02/13/2025 8,485 $244,962   100.00% 0.03%
GSA CAPITAL PARTNERS LLP 02/07/2025 8,385 $242,000   -19.04% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 7,914 $229,318   14.55% 0.03%
ALLIANCEBERNSTEIN L.P. 02/12/2025 7,586 $219,008   -18.83% 0.03%
D. E. SHAW & CO., INC. 02/14/2025 7,447 $214,995   100.00% 0.03%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 7,446 $214,966   100.00% 0.03%
COREBRIDGE FINANCIAL, INC. 02/11/2025 6,245 $180,293   -7.01% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 5,831 $168,341   100.00% 0.02%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 3,493 $101,000   0.00% 0.01%
02/11/2025 2,525 $72,897   100.00% 0.01%
VIRTUS ETF ADVISERS LLC 02/14/2025 2,309 $66,661   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 1,860 $53,698   162.34% 0.01%

LENZ Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 69 institutional investors and hedge funds held shares of LENZ Therapeutics, Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 4.18 M

Alpha Wave Global, LP: 3.61 M

BlackRock, Inc.: 1.16 M

72 Investment Holdings, LLC: 1.02 M

Samsara BioCapital, LLC: 986,981

SECTORAL ASSET MANAGEMENT INC: 977,245

71.26% of LENZ Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 17.73 M shares in the last 24 months. This purchase volume represents approximately $359.19 M in transactions.